Innovative Drug Modalities for the Treatment of Advanced Prostate ...

Prostate cancer, a prevalent malignancy affecting the prostate gland, is a significant global health concern. Androgen-deprivation therapy ...

Androgen-deprivation therapy (ADT) has proven effective in controlling advanced disease, with over 50% of patients surviving at the 10-year mark. However, a ...

Promising New Options for Treating Aggressive Prostate Cancer

Cedars-Sinai Cancer investigators have identified two promising new treatment options for men with recurrent prostate cancer—both of which ...

Antibody-Drug Conjugates in Prostate Cancer: Where Are we?

Innovative Drug Modalities for the Treatment of Advanced Prostate Cancer. 2024, Diseases. Prostate-Specific Membrane Antigen: Gateway to Management of ...

Emerging novel therapies for advanced prostate cancer - PMC

Currently two new drugs, abiraterone and cabazitaxel, are approved for patients with metastatic prostate cancer post docetaxel. Both drugs seem equally ...

What's New in Prostate Cancer Research?

Current treatment methods, such as intensity-modulated radiation therapy (IMRT) and proton beam radiation, help doctors avoid giving ...

9 Innovative Prostate Cancer Treatment Options

They may include new drugs or drug combinations, new approaches to prostate cancer surgery, different forms of radiation therapy, or some combination of all ...

Advances in Prostate Cancer Research - NCI

These changes may make men with metastatic prostate cancers candidates for what are called “basket” clinical trials of new drugs. Such trials ...

Unleashing novel horizons in advanced prostate cancer treatment

Nanomedicine, with its targeted drug delivery capabilities, has emerged as a promising approach to enhance treatment efficacy and reduce adverse effects.

Use of Specialty Drugs for Advanced Prostate Cancer and Hospital ...

Treatment options for men with advanced prostate cancer have evolved in recent years, expanding from chemotherapy to oral specialty drugs ...

Exploring potential therapeutic combinations for castration-sensitive ...

Recently, the US Food and Drug Administration approved enzalutamide, a non-steroidal androgen receptor (AR) inhibitor, for the treatment of ...

A Biologic Drug-Device Combination Immunotherapy Shows ...

A Biologic Drug-Device Combination Immunotherapy Shows Promise for Patients with Metastatic Prostate Cancer.

The value of new drugs for advanced prostate cancer

Initially, men with prostate cancer are treated with medical or surgical castration. As the cancer progresses to metastatic castration-resistant ...

Advancing Prostate Cancer Care: Treatment Approaches to ...

Advancing Prostate Cancer Care: Treatment Approaches to Precision Medicine, Biomarker Innovations, and Equitable Access · Abstract · Practical ...

Free Full-Text | Innovative Drug Modalities for the Treatment ... - MDPI

Innovative Drug Modalities for the Treatment of Advanced Prostate Cancer. Diseases 2024, 12, 87. https://doi.org/10.3390/diseases12050087. AMA Style. Capuozzo ...

Recent advances and future perspectives in the therapeutics of ...

Chemotherapy, radiotherapy, and prostatectomy are standard treatment options. However, newer novel hormone therapy drugs with a better response ...

New drug for metastatic prostate cancer now also approved in Europe

13, 2022, for the treatment of metastatic prostate cancer carrying the surface molecule PSMA (prostate specific membrane antigen). The drug had ...

Targeted nanomedicine modalities for prostate cancer treatment

Treatment of PC at the different stages of the disease may include surgery, androgen deprivation therapy (ADT), chemotherapy and radiation therapy.

Prostate Cancer Research Program

Using A Novel Genetically Engineered Mouse Model to Identify New Drug Targets for Treatment-Resistant. Metastatic Prostate Cancer. Lloyd Trotman, Ph.D.

Xtandi Approved for High-Risk Prostate Cancer - NCI

It's already approved by FDA to treat nonmetastatic and metastatic prostate cancer, including when the cancer can no longer be controlled with ...